Skip to main content
. 2012 Jul 13;72(6):858–862. doi: 10.1136/annrheumdis-2012-201456

Table 3.

Major outcomes at the 12-month follow-up, following DAS28 cut-off points and ACR remission criteria, in the follow-up cohort

Disease activity status (T12) No (%) of patients (total 481)
ACR remission 73 (15.2%)
DAS28 status
 Remission (≤2.6) 165 (34.3%)
 Low disease activity (2.6–3.2) 88 (18.3%)
 Moderate disease activity (3.2–5.1) 170 (35.3%)
 High disease activity (>5.1) 58 (12.1%)

ACR, American College of Rheumatology; DAS28, disease activity score in 28 joints; T12, 12-month follow-up.